Literature DB >> 27238725

Design and synthesis of N-substituted-2-hydroxyiminoacetamides and interactions with cholinesterases.

Nikola Maraković1, Anamarija Knežević2, Vladimir Vinković2, Zrinka Kovarik1, Goran Šinko3.   

Abstract

Within this study, we designed and synthesized four new oxime compounds of the N-substituted 2-hydroxyiminoacetamide structure and evaluated their interactions with acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Our aim was to explore the possibility of extending the dual-binding mode of interaction between the enzyme and the inhibitor to a so-called triple-binding mode of interaction through the introduction of an additional binding moiety. N-substituted 2-hydroxyiminoacetamide 1 was prepared via BOP catalyzed amidation of hydroxyiminoacetic acid with 3-azido-1-phenylpropylamine. An azide group enabled us to prepare more elaborate structures 2-4 by the copper-catalyzed azide-alkyne cycloaddition. The new compounds 1-4 differed in their presumed AChE peripheral site binding moiety, which ranged from an azide group to functionalized heterocycles. Molecular docking studies revealed that all three binding moieties are involved in the non-covalent interactions with ChEs for all of the four compounds, albeit not always in the complete accordance with the proposed hypothesis. All of the four compounds reversibly inhibited the ChEs with their inhibition potency increasing in the same order for both enzymes (1 < 2 < 4 < 3). A higher preference for binding to BChE (KI from 0.30 μmol/L to 130 μmol/L) over AChE (KI from 50 μmol/L to 1200 μmol/L) was observed for all of the compounds. Compounds were screened for reactivation of cyclosarin-, sarin- and VX-inhibited AChE and BChE. Copyright Â
© 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Azide-alkyne cycloaddition; Inhibition; Organophosphorus compounds; Oxime antidotes; Selectivity

Mesh:

Substances:

Year:  2016        PMID: 27238725     DOI: 10.1016/j.cbi.2016.05.035

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  7 in total

1.  Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases.

Authors:  Nikolina Maček Hrvat; Jarosław Kalisiak; Goran Šinko; Zoran Radić; K Barry Sharpless; Palmer Taylor; Zrinka Kovarik
Journal:  Toxicol Lett       Date:  2019-12-19       Impact factor: 4.372

2.  Design and evaluation of selective butyrylcholinesterase inhibitors based on Cinchona alkaloid scaffold.

Authors:  Anita Bosak; Alma Ramić; Tamara Šmidlehner; Tomica Hrenar; Ines Primožič; Zrinka Kovarik
Journal:  PLoS One       Date:  2018-10-05       Impact factor: 3.240

3.  Use of connectivity index and simple topological parameters for estimating the inhibition potency of acetylcholinesterase.

Authors:  Ante Miličević; Goran Šinko
Journal:  Saudi Pharm J       Date:  2022-02-08       Impact factor: 4.562

4.  Resorcinol-, catechol- and saligenin-based bronchodilating β2-agonists as inhibitors of human cholinesterase activity.

Authors:  Anita Bosak; Anamarija Knežević; Ivana Gazić Smilović; Goran Šinko; Zrinka Kovarik
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

5.  Interactions of Paraoxonase-1 with Pharmacologically Relevant Carbamates.

Authors:  Anita Bosak; Aljoša Bavec; Tilen Konte; Goran Šinko; Zrinka Kovarik; Marko Goličnik
Journal:  Molecules       Date:  2020-01-04       Impact factor: 4.411

Review 6.  Counteracting poisoning with chemical warfare nerve agents.

Authors:  Nikolina Maček Hrvat; Zrinka Kovarik
Journal:  Arh Hig Rada Toksikol       Date:  2020-12-31       Impact factor: 2.078

7.  Assessment of four organophosphorus pesticides as inhibitors of human acetylcholinesterase and butyrylcholinesterase.

Authors:  Tena Čadež; Dora Kolić; Goran Šinko; Zrinka Kovarik
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.